INS and polycystic ovary syndrome: These adverse outcomes may stem from the direct impact of hypoxaemia on glucose and insulin regulation (104) as well as the inflammatory mediators and altered insulin signaling associated with pulmonary dysfunction (105, 106), potentially exacerbating the metabolic manifestations of PCOS.